NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.
Lynch PM, Markowitz AJ, Mayer RJ, Weiss JM, Llor X, Ford JM, Giardiello FM, Lazenby AJ, Ahnen DJ, Klapman JB, Larson DW, Hampel H, Slavin TP Jr, Sugandha S, Ness RM, Shike M, Dwyer MA, Cooper G, Halverson AL, Provenzale D, Gupta S, Regenbogen SE, Hamilton SR, Grady W, Ogba N, Samadder NJ, Hall MJ, Chung DC, Bray T, Early DS
J Natl Compr Canc Netw 15 1465-1475 12/01/2017
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provide recommendations for the management of patients with high-risk syndromes associated with an increased risk of colorectal cancer (CRC). The NCCN Panel for Genetic/Familial High-Risk Assessment: Colorectal meets at least annually to assess comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. These NCCN Guidelines Insights focus on genes newly associated with CRC risk on multigene panels, the associated evidence, and currently recommended management strategies.